Skip to Main Content

Paper Details

Lesion-Based Radiomics Signature in Pretherapy 18F-FDG PET Predicts Treatment Response to Ibrutinib in Lymphoma.
Clin Nucl Med
6
2022
Author NameAffiliation
Tinsu Pan
Linghua WangThe University of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2